HFWA(HFWA)
HFWA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $336M | $362M |
| Low | $334M | $358M |
| High | $337M | $368M |
| EBITDA Avg | $100M | $107M |
| Low | $99M | $106M |
| High | $100M | $109M |
| EBIT Avg | $101M | $109M |
| Low | $101M | $108M |
| High | $102M | $111M |
| Net Income Avg | $68M | $91M |
| Low | $65M | $85M |
| High | $72M | $97M |
| EPS Avg | $1.98 | $2.65 |
| Low | $1.88 | $2.47 |
| High | $2.10 | $2.81 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $86M | $87M | $87M | $90M | $92M | $93M |
| Low | $86M | $86M | $87M | $89M | $91M | $93M |
| High | $86M | $89M | $88M | $90M | $93M | $94M |
| EBITDA Avg | $26M | $26M | $26M | $27M | $27M | $28M |
| Low | $25M | $26M | $26M | $26M | $27M | $27M |
| High | $26M | $26M | $26M | $27M | $27M | $28M |
| EBIT Avg | $26M | $26M | $26M | $27M | $28M | $28M |
| Low | $26M | $26M | $26M | $27M | $28M | $28M |
| High | $26M | $27M | $27M | $27M | $28M | $28M |
| Net Income Avg | $20M | $24M | $25M | $26M | $28M | $29M |
| Low | $17M | $22M | $24M | $26M | $27M | $28M |
| High | $23M | $26M | $25M | $26M | $28M | $29M |
| EPS Avg | $0.49 | $0.58 | $0.61 | $0.65 | $0.69 | $0.71 |
| Low | $0.43 | $0.54 | $0.60 | $0.64 | $0.68 | $0.70 |
| High | $0.57 | $0.63 | $0.62 | $0.65 | $0.69 | $0.72 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 4 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |